Adding PD-1 Inhibitor to Neoadjuvant and Adjuvant for NPC
Jiangxi Provincial Cancer Hospital
Jiangxi Provincial Cancer Hospital
Shandong University
Jiangxi Provincial Cancer Hospital
Centre de recherche du Centre hospitalier universitaire de Sherbrooke
Shantou University Medical College
Shantou University Medical College
National Cancer Centre, Singapore
Ain Shams University
University Health Network, Toronto
Guangxi Medical University
Guangxi Medical University
Sun Yat-sen University
National Cancer Centre, Singapore
University of Aleppo
University Medical Center Groningen
Tanta University
Assistance Publique - Hôpitaux de Paris
Fondazione Italiana Linfomi - ETS
Fujian Medical University Union Hospital
Seoul National University Hospital
UMC Utrecht
Uppsala University Hospital
Fudan University
Guangdong Provincial People's Hospital
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Instituto Brasileiro de Controle do Cancer
Hôpital Franco-Britannique-Fondation Cognacq-Jay
Mỹ Đức Hospital
Post Graduate Institute of Medical Education and Research, Chandigarh
Leiden University Medical Center
Hospital Israelita Albert Einstein
The Second Affiliated Hospital of Kunming Medical University
GERCOR - Multidisciplinary Oncology Cooperative Group
Jinling Hospital, China
Alliance for Clinical Trials in Oncology
Eastern Virginia Medical School
Centre Leon Berard
Sun Yat-sen University
Zhongnan Hospital
Fudan University
Sun Yat-sen University
Tianjin Medical University Cancer Institute and Hospital
Biotech Pharmaceutical Co., Ltd.
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Immune Oncology Research Institute
European Institute of Oncology
European Institute of Oncology
Instituto Nacional de Cancerologia de Mexico
Seoul National University Hospital
Leiden University Medical Center